These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 778303)

  • 21. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
    Brorson JE; Norrby R
    Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150
    [No Abstract]   [Full Text] [Related]  

  • 22. Paradoxical susceptibility to cephalothin and cefamandole of a Klebsiella pneumoniae isolate producing extended-spectrum beta-lactamase (TEM-3).
    Gaillot O; Mallea M; Philippon A; Pages JM; Simonet M
    J Antimicrob Chemother; 1996 Jan; 37(1):194-6. PubMed ID: 8647766
    [No Abstract]   [Full Text] [Related]  

  • 23. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae.
    Phillips I; Shannon K
    Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine.
    Piantieri G; Cafarelli A; Magliulo E
    G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524
    [No Abstract]   [Full Text] [Related]  

  • 25. Another look at differences in the susceptibility of Escherichia coli and Klebsiella pneumoniae to cephalothin and cefazolin.
    Yeh LL; Chi CL
    Int J Antimicrob Agents; 2001 Jun; 17(6):521-4. PubMed ID: 11397625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T; Mitsuhashi S
    Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.
    Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1979 Jun; 15(6):792-7. PubMed ID: 314270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The distribution of minimal inhibitory concentrations of recently introduced cephalosporins in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. as revealed by zone sizes of a standardized agar diffusion test (author's transl)].
    Schröter G; Loch R
    Zentralbl Bakteriol Orig A; 1979; 245(3):317-23. PubMed ID: 44786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study of the "in vitro" sensitivity of cefoxitin and cephalosporins].
    Torres A; Aguirre M; Ales JM
    Rev Clin Esp; 1979 Nov; 155(4):249-52. PubMed ID: 542674
    [No Abstract]   [Full Text] [Related]  

  • 30. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro bactericidal action of cephalosporins in different concentrations of serum.
    Magliulo E; Ceccarelli G; Bianchi PP; Piantieri G; Cafarelli A
    G Batteriol Virol Immunol; 1981; 74(1-6):39-47. PubMed ID: 6458527
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cefoxitin, a new beta-lactamase stable antibiotic].
    Simon C; Meyer E; Malerczyk
    Arzneimittelforschung; 1978; 28(9):1541-5. PubMed ID: 314296
    [No Abstract]   [Full Text] [Related]  

  • 34. Susceptibility of clinical isolates of bacteria to cefoxitin and cephalothin.
    Moellering RC; Dray M; Kunz LJ
    Antimicrob Agents Chemother; 1974 Sep; 6(3):320-3. PubMed ID: 15830480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of clinical strains of bacteria to cefoxitin.
    Bremner DA
    N Z Med J; 1981 Sep; 94(691):173-4. PubMed ID: 6945507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the variations in inoculum on the cephalosporins' in vitro antibacterial activity.
    Cafarelli A; Magliulo E; Piantieri G
    G Batteriol Virol Immunol; 1981; 74(1-6):26-38. PubMed ID: 6458525
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison of four recently introduced cephalosporins with respect to probability of resistance in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. (author's transl)].
    Loch R; Schröter G
    Zentralbl Bakteriol Orig A; 1979; 245(3):312-6. PubMed ID: 44785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro testing of newer cephalosporins (author's transl)].
    Linzenmeier G; Rosenthal E
    Infection; 1979; 7 Suppl 2():S225-7. PubMed ID: 437897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.